Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Soft Tissue Sarcoma · Sarcoma,Soft Tissue · Sarcoma · Soft Tissue Sarcoma Adult

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Study coordinator (Sandra D'Angelo, MD) · zzPDL_MED_Sarcoma_Clinical_Trials@mskcc.org · 646-888-4159

Study leads

Sandra D'Angelo, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

Sarcoma

Abroad (travel likely)RecruitingPHASE2

Aurora, United States

HTL0039732 in Participants With Advanced Solid Tumours

Neoplasms · Prostatic Neoplasms, Castration-Resistant · Stomach Neoplasms

Abroad (travel likely)RecruitingPHASE1, PHASE2

Cambridge, United Kingdom · Cardiff, United Kingdom

Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma

Sarcoma

Abroad (travel likely)RecruitingPHASE2

Santa Monica, United States

Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors

Lung Cancer · Liver Cancer · Colorectal Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Guangzhou, China